Table 1.
Methods for studying RTE biology
| Model system | Method | Advantages | Disadvantages | Refs |
|---|---|---|---|---|
| Intrathymic FITC injection | Labels developing thymocytes; FITC+ cells in the periphery are RTEs | Allows the phenotypic and functional analysis of the youngest RTEs by flow cytometry |
|
55,56 |
| BrdU incorporation | BrdU is taken up by dividing thymocytes; RTEs are BrdUlow | A non-surgical procedure that allows the analysis of RTE phenotype |
|
57 |
| TRECs | Quantification by PCR of excised DNA fragments generated during TCR rearrangement; RTEs are enriched for TRECs | Allows the determination of thymic output and the relative proportion of RTEs in the human T cell population |
|
58,59 |
| Thymic lobe grafts | Congenic thymic lobes are grafted under the kidney capsule | Allows the phenotypic and functional analysis of RTEs by flow cytometry for up to 3 weeks |
|
18,60 |
| Fetal thymus organ culture | Fetal thymic lobes are placed in culture; RTEs are harvested 1–12 days later | Allows the phenotypic and functional analysis of RTEs by flow cytometry |
|
24 |
| RAG2–GFP transgenic mice or RAG1–GFP knock-in mice | GFP signal remains detectable after RAG expression has ceased; GFP+ peripheral T cells are RTEs | Allows the phenotypic and functional analysis of RTEs from unmanipulated mice, and GFP signal intensity correlates with time since thymic egress |
|
9,47,61 |
| Cell surface phenotype | Mouse RTEs are QA2lowCD24hi | Allows for phenotypic and functional analysis of RTEs by flow cytometry |
|
9 |
| Human RTEs are CD31+PTK7+ |
|
3,62 |
BrdU, 5-bromodeoxyuridine; FITC, fluorescein isothiocyanate; GFP, green fluorescent protein; PTK7, protein tyrosine kinase 7; RAG, recombination-activating gene; RTE, recent thymic emigrant; TCR, T cell receptor; TREC, TCR, rearrangement excision circle.